Lixte Biotechnology Holdings, Inc.
LIXT
$3.46
$0.175.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -65.81% | -59.44% | -75.28% | -67.93% | -10.91% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 41.57% | 33.64% | 293.36% | 0.39% | -30.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -62.90% | -57.81% | -73.41% | -67.73% | -13.81% |
|
|
|||||
| Total Current Assets | -62.90% | -57.81% | -73.41% | -67.73% | -13.81% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -55.44% | -57.81% | -73.41% | -67.60% | -13.81% |
|
|
|||||
| Total Accounts Payable | -37.52% | -45.89% | -53.78% | -58.88% | -59.44% |
| Total Accrued Expenses | -- | -- | -24.24% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 53.40% | 12.26% | 49.65% | 182.67% | 703.60% |
| Total Other Current Liabilities | 53.40% | 12.26% | 49.65% | 182.67% | 703.60% |
| Total Current Liabilities | 27.43% | -23.27% | 1.40% | 5.55% | 4.69% |
|
|
|||||
| Total Current Liabilities | 27.43% | -23.27% | 1.40% | 5.55% | 4.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.43% | -23.27% | 1.40% | 5.55% | 4.69% |
|
|
|||||
| Common Stock & APIC | 10.15% | 2.76% | 0.85% | 0.91% | 7.86% |
| Retained Earnings | -6.12% | -6.72% | -7.40% | -8.43% | -8.69% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 151.96% | -526.58% | -640.18% | -249.90% | -55.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 151.96% | -526.58% | -640.18% | -249.90% | -55.28% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -70.99% | -62.93% | -79.29% | -72.23% | -16.58% |
|
|
|||||